We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

It’s that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more sinister threat: RSV.

The truth is 80% of babies under 1 year old catch RSV. “They probably mostly catch it from other children,” said Andrew Pavia, MD, Pediatric Infectious Disease at University of Utah Health/Primary ...

The Oregon Health Authority and public health officials said a winter, fall surge of COVID-19 and the flu are likely.

Mary Washington Healthcare with information to protect your family from RSV--including infants and older adults.

The rates of respiratory syncytial virus-associated hospitalizations were three to nine times higher for assisted living residents compared with the rates for community-dwelling older adults in a ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

New Hampshire and the rest of the U.S. are experiencing high levels of COVID-19 as detected through wastewater.

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...